Please note: these dates are applicable ONLY for applications that are complete (deemed suitable for IRB review) by a submission deadline above AND determined by the OHSP/IRB to require Convened IRB review at scheduled monthly meeting. To see how an application may be reviewed or require convened IRB review, click on the IRB Review Pathways panel on our Human Research Review page.

*Applications are NOT considered complete for any purpose if, for example, ANY the following are insufficient, missing, or incorrect: (1) required RAMP IRB SmartForm information in applicable pages/sections; (2) ALL study materials (e.g., study protocol (i.e., research plan), consent/recruitment documents, instruments/measures/questionnaires (and anything else that human study participants will read, see, hear or be asked to provide or complete), product labels for approved or investigative drug/device/supplements and applicable FDA approvals or clearances, etc.); (3) completion of current human subjects research training (and Good Clinical Practice training for NIH-funded or FDA-regulated clinical trials); (4) satisfactory CAMS/conflicts of interest (COI) review or outcomes for all study staff; (5) faculty advisor approval for student-led research; (6) use of only current and correct FSU-approved templates; and/or (7) satisfactory responses to any requests for clarifications or required modifications. For researchers providing study participants with any clinical care, a CV and/or current state licensure may be required. The IRB may at any time require additional documentation. Applications deemed not suitable for IRB review will be returned to researchers for completion and may, only if subsequently deemed suitable for IRB review, be added to the IRB agenda for another month's meeting.